Business Review Weekly 2000 Beth QUinlivan |
Title | Subject | Authors |
After Mayne Nickless, a new use-by date.(Barry Catchlove, principal adviser, health and community services, KPMG Consulting) | Business, general | Beth Quinlivan |
A lingering malaise: the big three private hospital companies have had a nerve-racking year. | Business, general | Beth Quinlivan |
Art for money's sake. | Business, general | Beth Quinlivan |
Biotechnology comes to life.(investment advice) | Business, general | Beth Quinlivan |
Cell specialists chase broad cure.(BresaGen, research into treatment for Parkinson's disease) | Business, general | Beth Quinlivan |
Corporate medicine.(general practitioners in Australia joining medical companies) | Business, general | Beth Quinlivan |
Drug net hits pharmacists.(includes related article) | Business, general | Beth Quinlivan |
Farmers just love their new cotton genes.(genetically modified cotton) | Business, general | Beth Quinlivan |
FBT and the entertainment factor.(fringe benefits tax) | Business, general | Beth Quinlivan |
Genes breakthrough.(potential floatation of Australian biotech firm Benitec) | Business, general | Beth Quinlivan |
Health rivalries fierce.(includes related article)(biotechnology industry)(Cover Story) | Business, general | Beth Quinlivan |
Health shapes up as another e-sector.(growth of online health services) | Business, general | Beth Quinlivan |
Navigating the DIY super maze. | Business, general | Beth Quinlivan |
On the trail of the profitable proteins.(investing in biotechnology firms) | Business, general | Beth Quinlivan |
Private hospitals in recovery ward.(private hospital operators) | Business, general | Beth Quinlivan |
Research closes in on a weighty problem.(research into obesity) | Business, general | Beth Quinlivan |
Sonic's boom comes at a cost.(the cost of Sonic Healthcare's acquisitions) | Business, general | Beth Quinlivan |
Super survives as a lower-risk way to beat inflation.(changes to the Australian tax system implications for the superannuation scheme) | Business, general | Beth Quinlivan |
The biotech boom.(includes related article) | Business, general | Beth Quinlivan |
The genome gold rush.(implications for biotechnology industry of the Human Genome Project) | Business, general | Beth Quinlivan |
The marvels of science.(investments in biotechnology) | Business, general | Beth Quinlivan |
The promise of miracles.(includes related article) | Business, general | Beth Quinlivan |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.